Lipids and CV Risks Survey – Report

TMA conducted a survey on Lipids and cardiovascular risks on its website from September 1st to October 31st, 2016.

TMA website visitors were asked to fulfill a 17-item online questionnaire. Fifty-four of you participated in this survey and we thank you for your time.


After analyzing the answers, we are now able to better understand lipid guidelines uses and daily practices and also of physicians point of view. This is a very useful approach to improve those recommendations.

This report will help guidelines developers and experts to have a better understanding of the unmet needs and knowledge gaps and enable them to work further.

Ask for report

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the leading cause of premature mortality in Europe, US, and is also increasingly common in developing countries. Prevention and treatment of dyslipidemias should always be considered within the broader framework of CVD prevention.

Guidelines summarize and evaluate all available evidence with the objective of assisting physicians in selecting the best management strategies for an individual patient with a specific condition, while taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help physicians to make decisions in their daily practice.

Different guidelines for dyslipidemias exist in Europe and US, regularly updated, but not always known and implemented or used by physicians and patients.


As promised, TMA donated 1€ per participant to “Coeur de la Tour” a Swiss Foundation which supports projects in cardiovascular medicine.

Fifty-four physicians participated in the survey, 28 (52%) were primary care physicians and 26 (48%) were specialists

A vast majority of participants declared implementing lipids guidelines for the management of their dyslipidemic patients.

50% find these guidelines very useful in their daily practice.

Our next survey deals with Chronic Obstructive Pulmonary Disease – want to participate?

Ask for link when on line